LeMaitre Vascular, Inc. specializes in the development and commercialization of medical devices for peripheral vascular, cardiovascular, and end-stage renal diseases. The company's portfolio includes over 15 niche product lines, featuring items such as valvulotomes, carotid shunts, embolectomy catheters, and biologic patches like the XenoSure bovine patch. In addition to manufacturing devices, LeMaitre offers human tissue cryopreservation services. The company operates a direct sales model targeting hospitals and surgical centers across more than 25 countries, supplemented by a network of distributors reaching over 70 countries worldwide. Its strategic focus centers on acquiring and developing low-rivalry, niche vascular products to leverage its established global sales force.
